Product Code: M770-01-00-00-00
Abstract
The aim of this research study is to thoroughly assess and analyse the
biosimilars market, as well as market and technology trends in Europe, in
order to provide strategic recommendations for the success of market
participants. This study is focused on established segments in Europe
including Erythropoietin, Granulocyte Colony Stimulating Factors, Human Growth
Hormones and emerging segments including monoclonal antibodies, Insulin and
interferon. The established market segments consist of products currently
approved and marketed in Europe. New therapeutic classes of drugs are expected
to be a major contributor in the emerging market segments.
Table of Contents
1. Executive Summary
Summary of European Biosimilars Market
2. Total Biosimilars Market
Introduction to the Total Biosimilars Market
- Total Biosimilars Market Overview
- Forecast and Trends - Global Biosimilars Market
- Market Share and Competitive Analysis - Global Biosimilars Market
3. European Biosimilars Market
Introduction to European Biosimilars Market
- European Biosimilars Market Overview
- Challenges; Drivers and Restraints - European Biosimilars Market
- Forecast and Trends - European Biosimilars Market
- Demand Analysis - European Biosimilars Market
- Market Share and Competitive Analysis - European Biosimilars Market
- Regulatory Guidelines - European Biosimilars Market
European Erythropoietin Biosimilars Market
- European Erythropoietin Biosimilars Market Overview
- Forecast and Trends - European Erythropoietin Biosimilars Market
- Market Share and Competitive Analysis - European Erythropoietin
Biosimilars Market
- Regulatory Guidelines - European Erythropoietin Biosimilars Market
European Granulocyte Colony Stimulating Factors Biosimilars Market
- European Granulocyte Colony Stimulating Factors Biosimilars Market Overview
- Forecast and Trends - European Granulocyte Colony Stimulating Factors
Biosimilars Market
- Market Share and Competitive Analysis - European Granulocyte Colony
Stimulating Factors Biosimilars Market
- Regulatory Guidelines - European Granulocyte Colony Stimulating Factors
Biosimilars Market
European Human Growth Hormone Biosimilars Market
- European Human Growth Hormone Biosimilars Market Overview
- Forecast and Trends - European Human Growth Hormone Biosimilars Market
- Market Share and Competitive Analysis - European Human Growth Hormone
Biosimilars Market
- Regulatory Guidelines - European Human Growth Hormone Biosimilars Market
European Monoclonal Antibodies Biosimilars Market
- European Monoclonal Antibodies Biosimilars Market Overview
- Market Analysis - European Monoclonal Antibodies Biosimilars Market
- Regulatory Guidelines - European Monoclonal Antibodies Biosimilars Market
European Insulin Biosimilars Market
- European Insulin Biosimilars Market Overview
- Market Analysis - European Insulin Biosimilars Market
- Regulatory Guidelines - European Insulin Biosimilars Market
European Interferon Biosimilars Market
- European Interferon Biosimilars Market Overview
- Market Analysis - European Interferon Biosimilars Market
- Regulatory Guidelines - European Interferon Biosimilars Market
4. Regional Analysis of European Biosimilars Market
Biosimilars Market - The United Kingdom
- The United Kingdom Biosimilars Market Overview
- Forecast and Trends - The United Kingdom Biosimilars Market
Biosimilars Market - Germany
- Germany Biosimilars Market Overview
- Forecast and Trends - Germany Biosimilars Market
Biosimilars Market - France
- France Biosimilars Market Overview
- Forecast and Trends - France Biosimilars Market
Biosimilars Market - Italy
- Italy Biosimilars Market Overview
- Forecast and Trends - Italy Biosimilars Market
Biosimilars Market - Spain
- Spain Biosimilars Market Overview
- Forecast and Trends - Spain Biosimilars Market
Biosimilars Market - Benelux
- Benelux Biosimilars Market Overview
- Forecast and Trends - Benelux Biosimilars Market
Biosimilars Market - Scandinavia
- Scandinavia Biosimilars Market Overview
- Forecast and Trends - Scandinavia Biosimilars Market
5. Product Profiling
Products in the Biosimilars Market
- Product Profiling - Biosimilars in Europe
- Product Profiling - Biologics
- Future Landscape Analysis
6. Conclusions and Strategic Recommendations
Conclusions of the study and Strategic Recommendations for Market Participants
- Conclusions and Strategic Recommendations
- The Last Word
7. Appendix
Data Tables
- Decision Support Databases
- Abbreviations
- Market Engineering Methodology
